A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

Cited by (1,005)

Items 301–400 of 1,005

1. Adverse prognosis of incidentally detected ambulatory atrial fibrillation
   Carlos Martínez, Anja Katholing, Saul Benedict Freedman · 2014 · Thrombosis and Haemostasis
2. The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
   Victor J. Dzau, Elliott Marshall Antman, Henry R. Black, David L. Hayes, JoAnn Elisabeth Manson, Jorge Plutzky, Jeffrey J. Popma, William G. Stevenson · 2006 · Circulation
3. Newly Diagnosed Atrial Fibrillation
   Richard L. Page · 2004 · New England Journal of Medicine
4. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
   Yasuhiro Hamatani, Hisashi Ogawa, Kensuke Takabayashi, Yugo Yamashita, Daisuke Takagi, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa et al. · 2016 · Scientific Reports
5. Targeted Modification of Atrial Electrophysiology by Homogeneous Transmural Atrial Gene Transfer
   Kan Kikuchi, Amy D. McDonald, Tetsuo Sasano, J. Kevin Donahue · 2005 · Circulation
6. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFÉ-II Study)
   F.A. Cuoco · 2010 · Yearbook of Cardiology
7. Asymptomatic Atrial Fibrillation
   Robert W. Rho, Richard L. Page · 2005 · Progress in Cardiovascular Diseases
8. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
   Luca Testa, Giuseppe Biondi‐Zoccai, Antonio Dello Russo, Fulvio Bellocci, Felicita Andreotti, Filippo Crea · 2005 · European Heart Journal
9. Catheter Ablation of Supraventricular Arrhythmias:
   Fred Morady · 2004 · Journal of Cardiovascular Electrophysiology
10. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management
    Anne M. Gillis, Atul Verma, Mario R. Talajic, Stanley Nattel, Paul Dorian · 2011 · Canadian Journal of Cardiology
11. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
    Seiji Habara, Keigo Dote, Masashi Kato, S. Sasaki, Kenji Goto, Hiroaki Takemoto, Daiji Hasegawa, Osamu Matsuda · 2007 · European Heart Journal
12. Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
    Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Deirdre A. Lane, Gregory Y.H. Lip · 2020 · Journal of the American Heart Association
13. Rate-Control Treatment and Mortality in Atrial Fibrillation
    Tze‐Fan Chao, Chia‐Jen Liu, Ta‐Chuan Tuan, Su‐Jung Chen, Kang-Ling Wang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Tzeng‐Ji Chen et al. · 2015 · Circulation
14. Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry
    MATTHEW R. REYNOLDS, Vidal Essebag, PETER J. ZIMETBAUM, David J. Cohen · 2007 · Journal of Cardiovascular Electrophysiology
15. Detection of Atrial Fibrillation by Implanted Devices with Wireless Data Transmission Capability
    Niraj Varma, Bruce Sheldon Stambler, Sung Chun · 2005 · Pacing and Clinical Electrophysiology
16. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
    Stanley G. Rockson, Gregory W. Albers · 2004 · Journal of the American College of Cardiology
17. Atrial fibrillation and heart failure: natural history and pharmacological treatment
    Irene Savelieva, A JOHNCAMM · 2004 · EP Europace
18. Guidelines for Treatment of Acute Heart Failure (JCS 2011)
    JCS Joint Working Group · 2013 · Circulation Journal
19. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial
    Lars Eckardt, Susanne Sehner, Anna Isabella Suling, Katrin Borof, GÜNTER E. BREITHARDT, Harry J.G.M. Crijns, Andreas Goette, Karl Wegscheider, Antonia Zapf, A. John Camm et al. · 2022 · European Heart Journal
20. Why Atrial Fibrillation Ablation Should Be Considered First-Line Therapy for Some Patients
    Atul Verma, Andrea Natale · 2005 · Circulation
21. A Prospective, Randomized Trial of an Emergency Department Observation Unit for Acute Onset Atrial Fibrillation
    Wyatt W. Decker, Peter A. Smars, Lekshmi Vaidyanathan, Deepi G. Goyal, Eric T. Boie, Latha Ganti, Douglas L. Packer, Thomas D. Meloy, Andy J. Boggust, Luis H. Haro et al. · 2008 · Annals of Emergency Medicine
22. Catheter ablation of atrial fibrillation guided by complex fractionated atrial electrogram mapping of atrial fibrillation substrate
    Koonlawee Nademanee, Evan E. Lockwood, Naoya Oketani, Brett Gidney · 2009 · Journal of Cardiology
23. Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association
    Janice Y. Chyou, Ebrahim Barkoudah, Jonathan Walter Dukes, Larry B. Goldstein, José A. Joglar, Anson M. Lee, Steven A. Lubitz, Keith A. Marill, Kevin Sneed, Megan M. Streur et al. · 2023 · Circulation
24. Treatment of Atrial Fibrillation
    Eric N. Prystowsky, Benzy J. Padanilam, Richard Ira Fogel · 2015 · JAMA
25. Tachycardia‐Induced Cardiomyopathy: A Review of Literature
    Atul A. Khasnis, Krit Jongnarangsin, George S. Abela, Srikar Veerareddy, Vivek Yerrapu Reddy, Ranjan K. Thakur · 2005 · Pacing and Clinical Electrophysiology
26. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)
    Takeshi Yamashita, H. Inoue, K. Okumura, I. Kodama, Yoshifusa Aizawa, H. Atarashi, Tohru Ohe, Hiroshi Ohtsu, Takeshi Kato, S. Kamakura et al. · 2010 · EP Europace
27. Lenient vs. Strict Rate Control in Patients with Atrial Fibrillation and Heart Failure: A Post-Hoc Analysis of the RACE II Study
    Bart A. Mulder, Dirk Jan van Veldhuisen, Harry J.G.M. Crijns, Jan G.P. Tijssen, Hans L. Hillege, Marco Alings, Michiel Rienstra, Hessel F. Groenveld, Maarten P. van den Berg, Isabelle C. Van Gelder et al. · 2013 · European Journal of Heart Failure
28. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry
    Jonathan S. Steinberg, Niraj Varma, Iwona Cygankiewicz, Peter F. Aziz, Paweł Balsam, Adrian M Baranchuk, Daniel J. Cantillon, Polychronis Dilaveris, Sérgio Dubner, Nabil El‐Sherif et al. · 2017 · Annals of Noninvasive Electrocardiology
29. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: Results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study
    Vincent E. Hagens, Dirk Jan van Veldhuisen, Otto Kamp B, Michiel Rienstra, Hans A. Bosker, Nic J.G.M. Veeger, Jan G.P. Tijssen, Harry J.G.M. Crijns, Isabelle C. Van Gelder · 2004 · Heart Rhythm
30. Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter
    Ian Gilmour Stiell, Catherine M. Clement, Jeffrey Joseph Perry, Christian Vaillancourt, Cheryl Symington, Garth E. Dickinson, David H. Birnie, Martin S. Green · 2010 · Canadian Journal of Emergency Medicine
31. Variation in Management of Recent-Onset Atrial Fibrillation and Flutter Among Academic Hospital Emergency Departments
    Ian Gilmour Stiell, Catherine M. Clement, Robert James Brison, Brian Hunter Rowe, Bjug Borgundvaag, Trevor S. Langhan, Eddy Lang, Kirk D. Magee, Rob Stenstrom, Jeffrey Joseph Perry et al. · 2010 · Annals of Emergency Medicine
32. Atrial Fibrillation in Heart Failure: A Comprehensive Review
    PRAKASH C. DEEDWANIA, Joel A. Lardizabal · 2010 · The American Journal of Medicine
33. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy
    Cees B. de Vos, Günter Breithardt, A. John Camm, Paul Dorian, Peter Russell Kowey, Jean‐Yves Le Heuzey, Lisa Naditch‐Brûlé, Eric N. Prystowsky, Peter J. Schwartz, Christian Tobias Torp-Pedersen et al. · 2012 · American Heart Journal
34. Candesartan in the prevention of relapsing atrial fibrillation
    Arnljot Tveit, Irene Grundvold, Mona Olufsen, Ingebjørg Seljeflot, Michael Abdelnoor, Harald Arnesen, Pål Smith · 2006 · International Journal of Cardiology
35. Digoxin and mortality in atrial fibrillation: a prospective cohort study
    Hallberg, Pär, Lindbäck, Johan, Lindahl, Bertil, Stenestrand, Ulf, Melhus, Håkan, for the RIKS-HIA group · 2007 · European Journal of Clinical Pharmacology
36. Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
    Deborah Anne Marshall, Adrian R. Levy, Humberto J. Vidaillet Jr., Elisabeth A. L. Fenwick, April E Slee, Gordon Blackhouse, H.Leon Greene, D. George Wyse, Graham Nichol, Bernie J. OʼBrien et al. · 2004 · Annals of Internal Medicine
37. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study)
    Howard A. Cooper, Dennis A. Bloomfield, David E. Bush, Michael S. Katcher, Michele Rawlins, Joseph Sacco, Mary L. Chandler · 2004 · The American Journal of Cardiology
38. Atrial fibrillation from the pathologist’s perspective
    Domenico Corradi · 2013 · Cardiovascular Pathology
39. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis
    CHATTERJEE, SAURAV, SARDAR, PARTHA, LICHSTEIN, EDGAR, MUKHERJEE, DEBABRATA, AIKAT, SHAMIK · 2013 · Pacing and Clinical Electrophysiology
40. Atrial Fibrillation Therapy Now and in the Future
    Christopher E. Woods, Jeffrey E. Olgin · 2014 · Circulation Research
41. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
    Paulus F. Kirchhof, Jeroen Joost Bax, C Blomstrom-Lundquist, Hugh Calkins, Alan John Camm, Riccardo Cappato, Francisco G. Cosío, Harry J.G.M. Crijns, HC Diener, Andreas Goette et al. · 2009 · EP Europace
42. Quality of Life and Functional Capacity in Patients With Atrial Fibrillation and Congestive Heart Failure
    Irina Horduna, Denis Roy, Nancy Frasure‐Smith, Mario R. Talajic, François Lespérance, Lucie Blondeau, Paul Dorian, Paul Khairy · 2012 · Journal of the American College of Cardiology
43. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study
    Harry J.G.M. Crijns, Bob Weijs, Anna-Meagan Fairley, Thorsten Lewalter, Aldo Pietro Maggioni, Alfonso Martı́n, Piotr P. Ponikowski, Mårten Rosenqvist, Prashanthan Sanders, Maurício Scanavacca et al. · 2014 · International Journal of Cardiology
44. Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation
    Greg C. Flaker, Janice M. Pogue, Salim Yusuf, Marc Alan Pfeffer, Samuel Zachary Goldhaber, Christopher Bull Granger, Inder S. Anand, Robert G. Hart, Stuart J. Connolly · 2010 · Circulation Cardiovascular Quality and Outcomes
45. Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis and Systematic Review
    Chatterjee, Neal A., Upadhyay, Gaurav A., Ellenbogen, Kenneth A., McAlister, Finlay A., Choudhry, Niteesh K., Singh, Jagmeet P. · 2012 · Circulation Arrhythmia and Electrophysiology
46. Shared Decision Making in Atrial Fibrillation
    Luke Seaburg, Erik P. Hess, Megan J. Coylewright, Henry H. Ting, Christopher John McLeod, Víctor M. Montori · 2014 · Circulation
47. Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent
    David Fedida · 2007 · Expert Opinion on Investigational Drugs
48. The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation
    Jean‐Yves Le Heuzey, GÜNTER E. BREITHARDT, A. John Camm, Harry J.G.M. Crijns, Paul Dorian, Peter Russell Kowey, Ihsen Merioua, Eric N. Prystowsky, Peter J. Schwartz, Christian Tobias Torp-Pedersen et al. · 2009 · The American Journal of Cardiology
49. Risk factors for atrial fibrillation recurrence
    Enrico Vizzardi, Antonio Curnis, Maria Giulia Latini, Francesca Salghetti, Elena Rocco, Laura Lupi, Riccardo Rovetta, Filippo Quinzani, Ivano Bonadei, Luca Bontempi et al. · 2012 · Journal of Cardiovascular Medicine
50. Gender in atrial fibrillation: Ten years later
    Héctor I. Michelena, Brian D. Powell, Peter A. Brady, Paul A. Friedman, Michael D. Ezekowitz · 2010 · Gender Medicine
51. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective
    Won Chan Lee, Gervasio A. Lamas, Sanjeev Balu, James Robert Spalding, Qin Wang, Chris Leo Pashos · 2008 · Journal of Medical Economics
52. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
    Carmelo Lafuente‐Lafuente, Stéphane J. Mouly, Miguel Angel Longás-Tejero, Jean‐François Bergmann · 2007 · Cochrane Database of Systematic Reviews
53. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018
    David B. Brieger, John V. Amerena, John Attia, Beata V. Bajorek, Kim Hoe Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya L Hall, Haris M. Haqqani et al. · 2018 · The Medical Journal of Australia
54. Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
    Isabelle Nault, Shinsuke Miyazaki, Andreï Forclaz, Matthew James Wright, Amir Jadidi, Pierre Jaı̈s, Mélèze Hocini, Michel Haı̈ssaguerre · 2010 · European Heart Journal
55. Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart
    Kapil Kumar, Bruce D. Nearing, Marcelo Carvas, Bruno Nascimento, Mariana Acar, Luiz Belardinelli, Richard L. Verrier · 2009 · Journal of Cardiovascular Electrophysiology
56. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
    Marco Proietti, Valeria Raparelli, Brian Olshansky, Gregory Y.H. Lip · 2015 · Clinical Research in Cardiology
57. Patterns and Predictors of Warfarin Use in Patients With New-Onset Atrial Fibrillation from the FRACTAL Registry
    Matthew R. Reynolds, Jignesh S. Shah, Vidal Essebag, Brian Olshansky, Paul A. Friedman, Tom Hadjis, Robert Lemery, Tristram D. Bahnson, David S. Cannom, Mark E. Josephson et al. · 2006 · The American Journal of Cardiology
58. Diagnostic Approach and Treatment Strategy in Tachycardia‐induced Cardiomyopathy
    Young‐Hoon Jeong, Kee‐Joon Choi, Jong‐Min Song, Eui‐Seock Hwang, Kyoung‐Min Park, Gi‐Byoung Nam, Jae‐Joong Kim, You‐Ho Kim · 2008 · Clinical Cardiology
59. Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
    Paul S. Chan, Sandeep S. Vijan, Fred Morady, Hakan Oral · 2006 · Journal of the American College of Cardiology
60. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression
    Elizabeth S. Mearns, Charles Michael White, Christine G. Kohn, Jessica Hawthorne, Ju-Sung Song, Joy Meng, Jeff R. Schein, Monika Kumar Raut, Craig Ian Coleman · 2014 · Thrombosis Journal
61. Women and atrial fibrillation
    Annabelle Santos Volgman, Emelia J. Benjamin, Anne B. Curtis, Margaret C. Fang, Kathryn J. Lindley, Gerald V. Naccarelli, Carl J. Pepine, Odayme Quesada, Marmar Vaseghi, Albert L. Waldo et al. · 2020 · Journal of Cardiovascular Electrophysiology
62. Epidemiological Profile of Atrial Fibrillation: A Contemporary Perspective
    Teresa S.M. Tsang, Yoko Miyasaka, Marion E. Barnes, Bernard John Gersh · 2005 · Progress in Cardiovascular Diseases
63. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])
    Parkash, Ratika, Wells, George A., Sapp, John L., Healey, Jeffrey S., Tardif, Jean-Claude, Greiss, Isabelle, Rivard, Lena, Roux, Jean-Francois, Gula, Lorne, Nault, Isabelle et al. · 2017 · Circulation
64. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation
    Koonlawee Nademanee, Montawatt Amnueypol, Frances Lee, Carla M. Drew, Wanwimol Suwannasri, Mark Schwab, Gumpanart Veerakul · 2014 · Heart Rhythm
65. Management of atrial fibrillation in patients with heart failure
    Hans‐Ruprecht Neuberger, C. Mewis, Dirk Jan van Veldhuisen, Ulrich Schotten, Isabelle C. Van Gelder, Maurits A. Allessie, Michael Böhm · 2007 · European Heart Journal
66. Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care
    Jordi Heijman, Henry Sutanto, Harry J.G.M. Crijns, Stanley Nattel, Natalia A. Trayanova · 2021 · Cardiovascular Research
67. Accuracy of Mode Switch Algorithms for Detection of Atrial Tachyarrhythmias
    ROD S. PASSMAN, Kenneth M. Weinberg, Mark Freher, Andi Schaechter, Jeffrey J. Goldberger, Alan Howard Kadish · 2004 · Journal of Cardiovascular Electrophysiology
68. Atrial fibrillation: effects beyond the atrium?
    Rohan Sajeev Wijesurendra, Barbara Casadei · 2015 · Cardiovascular Research
69. Creation of a Genetic Calcium Channel Blocker by Targeted Gem Gene Transfer in the Heart
    Mitsushige Murata, Eugenio Cingolani, Amy D. McDonald, J. Kevin Donahue, Eduardo Marbán · 2004 · Circulation Research
70. Cardioembolic stroke
    Blaithnead Murtagh, Richard W. Smalling · 2006 · Current Atherosclerosis Reports
71. Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda : cardiovascular topics
    Emmy Okello, Zhang Wanzhu, Charles Musoke, Twalib Olega Aliku, Barbara Kakande, Peter Solomon Lwabi, Nyakoojo B Wilson, Charles Kiiza Mondo, Richard Odoi‐Adome, Juergen Freers · 2013 · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa
72. Correlation of Symptoms to ECG Diagnosis Following Atrial Fibrillation Ablation
    Hanno U. Klemm, Rodolfo Ventura, Thomas Rostock, Benedikt Brandstrup, Tim Risius, Thomas Meinertz, Stephan Willems · 2005 · Journal of Cardiovascular Electrophysiology
73. Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
    The ACTIVE Steering Committee · 2006 · American Heart Journal
74. Management of atrial fibrillation: Figure 1
    Gregory Y.H. Lip, Antonio Tello-Montoliu · 2006 · Heart
75. Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm: A Meta-analysis
    Letelier, Luz M., Udol, Kamol, Ena, Javier, Weaver, Bruce, Guyatt, Gordon H. · 2003 · Archives of Internal Medicine
76. Role of inflammation in early atrial fibrillation recurrence
    Marcelle D. Smit, A. H. Maass, Anne Margreet de Jong, Anneke C. Muller Kobold, Dirk Jan van Veldhuisen, Isabelle C. Van Gelder · 2012 · EP Europace
77. Incidence, Timing, Symptoms, and Risk Factors for Atrial Fibrillation After Cardiac Surgery
    Marjorie Funk, Sally Richards, Jill Desjardins, Christy Bebon, Heather Wilcox · 2003 · American Journal of Critical Care
78. Efficacy of Acupuncture in Preventing Atrial Fibrillation Recurrences After Electrical Cardioversion
    A Lomuscio, S. Belletti, Pier Maria Battezzati, Federico Lombardi · 2010 · Journal of Cardiovascular Electrophysiology
79. Sex Differences in Atrial Fibrillation
    Jason G. Andrade, Marc William Deyell, Andrea K.Y. Lee, Laurent Macle · 2017 · Canadian Journal of Cardiology
80. Catheter Ablation versus Standard Conventional Treatment in Patients with Left Ventricular Dysfunction and Atrial Fibrillation (CASTLE‐AF) ‐ Study Design
    NASSIR F. MARROUCHE, Johannes Brachmann · 2009 · Pacing and Clinical Electrophysiology
81. Left Atrial Strain Is Reduced in Patients with Atrial Fibrillation, Stroke or TIA, and Low Risk CHADS2 Scores
    Talhat Azemi, Vimal Rabdiya, Srilatha R. Ayirala, Louise D. McCullough, David I. Silverman · 2012 · Journal of the American Society of Echocardiography
82. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation
    Hugh G Calkins, Josép Brugada, Douglas L. Packer, Riccardo Cappato, S.-A. Chen, Harry J.G.M. Crijns, R. J. Damiano, D. Wyn Davies, David E. Haines, Michel Haı̈ssaguerre et al. · 2008 · EP Europace
83. Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines
    Christopher C. Cheung, Stanley Nattel, Laurent Macle, Jason G. Andrade · 2021 · Canadian Journal of Cardiology
84. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation
    Siu, Chung-Wah, Lau, Chu-Pak, Lee, Wai-Luen, Lam, Kwok-Fai, Tse, Hung-Fat · 2009 · Critical Care Medicine
85. Event‐Recorder Monitoring in the Diagnosis of Atrial Fibrillation in Symptomatic Patients: Subanalysis of the SOPAT Trial
    Monica Patten, Renke Maas, Amina Karim, HANS‐WALTER MÜLLER, ROSA SIMONOVSKY, Thomas Meinertz · 2006 · Journal of Cardiovascular Electrophysiology
86. A Common β1-Adrenergic Receptor Polymorphism Predicts Favorable Response to Rate-Control Therapy in Atrial Fibrillation
    Babar Parvez, Nagesh Chopra, Shane B. Rowan, Joseph C. Vaglio, Raafia Muhammad, Dan M. Roden, Dawood Darbar · 2011 · Journal of the American College of Cardiology
87. Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation
    Francesco Grigioni, Giovanni Benfari, Jean‐Louis Vanoverschelde, Christophe Tribouilloy, Jean-François Aviérinos, Francesca Bursi, Rakesh M. Suri, Federico Guerra, Agnès Pasquet, Dan Ruşinaru et al. · 2019 · Journal of the American College of Cardiology
88. Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure
    Jacob P. Kelly, A. Devore, Jing-jing Wu, B. Hammill, Abhinav K. Sharma, Lauren B. Cooper, G. Felker, J. Piccini, L. Allen, P. Heidenreich et al. · 2019 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
89. Secondary stroke prevention in people with atrial fibrillation: treatments and trials
    David Julian Seiffge, Virginia Cancelloni, Lorenz Räber, Maurizio Paciaroni, Andreas Metzner, Paulus F. Kirchhof, Urs Fischer, David John Werring, Ashkan Shoamanesh, Valeria Caso · 2024 · The Lancet Neurology
90. Atrial Fibrillation in Heart Failure Patients: Prevalence in Daily Practice and Effect on the Severity of Symptoms. Data from the ALPHA Study Registry
    Gaetano Maria De Ferrari, Catherine Klersy, Paolo Ferrero, Cecilia Fantoni, Diego Salerno‐Uriarte, Lorenzo Manca, Paolo Devecchi, Giulio Molon, Miriam Revera, Antonio Curnis et al. · 2006 · European Journal of Heart Failure
91. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
    Merritt H. Raitt, Annabelle Santos Volgman, Robert G. Zoble, Lyne Charbonneau, Farooq A. Padder, Gilles E O’Hara, David Kerr · 2006 · American Heart Journal
92. Electrical cardioversion of emergency department patients with atrial fibrillation
    John H. Burton, David R. Vinson, Kate Drummond, Tania D. Strout, Henry C. Thode, Jeff J. McInturff · 2004 · Annals of Emergency Medicine
93. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA)
    Paulus F. Kirchhof, Gerold Mönnig, Kristina Wasmer, Achim Heinecke, GÜNTER E. BREITHARDT, Lars Eckardt, Dirk Böcker · 2005 · European Heart Journal
94. Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation
    Gabriele Dell’Era, Elisa Rondano, Massimo Piergiuseppe Franchi, Paolo Nicola Marino, on behalf of the Novara Atrial Fibrillation (NAIF) Study Group · 2010 · European Journal of Echocardiography
95. Decade-long Trends in Atrial Fibrillation Incidence and Survival: A Community Study
    Alanna M. Chamberlain, Bernard John Gersh, Álvaro Alonso, Lin Y. Chen, Cecilia Berardi, Sheila M. Manemann, Jill M. Killian, Susan A. Weston, Veronique Lee Roger · 2014 · The American Journal of Medicine
96. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Gaita, Fiorenzo, Di Donna, Paolo, Olivotto, Iacopo, Scaglione, Marco, Ferrero, Ivana, Montefusco, Antonio, Caponi, Domenico, Conte, Maria Rosa, Nistri, Stefano, Cecchi, Franco · 2007 · The American Journal of Cardiology
97. Prevalence and Prognosis of Patients With Atrial Fibrillation in Japan
    Shinya S. Suzuki, Takeshi Yamashita, Takayuki Ohtsuka, Koichi Sagara, Tokuhisa Uejima, Yuji Oikawa, Junji Yajima, Akira Koike, Kazuyuki Nagashima, Hajime Kirigaya et al. · 2008 · Circulation Journal
98. Relation of Gender-Specific Risk of Ischemic Stroke in Patients With Atrial Fibrillation to Differences in Warfarin Anticoagulation Control (from AFFIRM)
    Renee M. Sullivan, Jingyang Zhang, Gideon Zamba, Gregory Y.H. Lip, Brian Olshansky · 2012 · The American Journal of Cardiology
99. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score–matched analysis
    Walid Saliba, Jorge E. Schliamser, Idit Lavi, Ofra Barnett‐Griness, Naomi Gronich, Gad Rennert · 2017 · Heart Rhythm
100. Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011)
     JCS Joint Working Group · 2012 · Circulation Journal